Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database

The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2 , and CYP2C9 and statin‐associated musculoskeletal symptoms

(2022) Rhonda M. Cooper‐DeHoff et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database

(2022) Philip J. Mease et al.   ADVANCES IN THERAPY

Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study

(2022) David Mannino et al.   RESPIRATORY MEDICINE

Opportunity for Genotype‐Guided Prescribing Among Adult Patients in 11 U.S. Health Systems

(2021) J. Kevin Hicks et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Identification of populations likely to benefit from pharmacogenomic testing

(2020) Craig William Heise et al.   Pharmacogenetics and Genomics

Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada

(2020) Mikayla Fan et al.   Pharmacogenetics and Genomics

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients

(2020) Laura B. Ramsey et al.   JAMA Network Open

Longitudinal exposure of English primary care patients to pharmacogenomic drugs: an analysis to inform design of pre‐emptive pharmacogenomic testing

(2019) James E. Kimpton et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later

(2019) Mary V. Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenomics

(2019) Dan M Roden et al.   LANCET

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

(2018) Nicholas L. Syn et al.   BMC Medicine

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

(2018) Larisa H. Cavallari et al.   JACC-Cardiovascular Interventions

Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes

(2018) Francesca Maria Notarangelo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty

(2017) Brian F. Gage et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

(2016) Matthias Samwald et al.   PLoS One

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

(2014) Kelly Caudle et al.   CURRENT DRUG METABOLISM

Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases

(2013) Marsha A. Raebel et al.   MEDICAL CARE

Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

(2012) J S Schildcrout et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

(2011) M V Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Trends in use of opioids for non-cancer pain conditions 2000–2005 in Commercial and Medicaid insurance plans: The TROUP study

(2008) Mark D. Sullivan et al.   PAIN